Indivisual Technology of Hanmi ‘Lapscovery’ New Drug Coming Soon

Hanmi has turned on its green light for commercialization of bio new drug that utilized lapscovery platform technology.

A neutropenia treatment, ‘LAPS-GCSF’, successfully finished the phase II clinical study and is going to start the phase III soon.

Hanmi is in the process of developing a new drug of various patterns that utilized the lapscovery platform technology, and it has turned out that...